Hemolytic Anemia–associated Pulmonary Hypertension of Sickle Cell Disease and the Nitric Oxide/Arginine Pathway
- 1 July 2003
- journal article
- Published by American Thoracic Society in American Journal of Respiratory and Critical Care Medicine
- Vol. 168 (1) , 3-4
- https://doi.org/10.1164/rccm.2304002
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Arginine TherapyAmerican Journal of Respiratory and Critical Care Medicine, 2003
- Pulmonary hypertension in sickle cell disease: cardiac catheterization results and survivalBlood, 2003
- Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell diseaseNature Medicine, 2002
- Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell diseaseProceedings of the National Academy of Sciences, 2001
- Pulmonary Complications of Sickle Cell AnemiaAmerican Journal of Respiratory and Critical Care Medicine, 2001
- SYSTEMIC FAT EMBOLISM AND PULMONARY HYPERTENSION IN SICKLE CELL DISEASEHematology/Oncology Clinics of North America, 1996
- Pulmonary hypertension in sickle cell diseaseThe American Journal of Cardiology, 1994
- Pulmonary Hypertension in Paroxysmal Nocturnal HemoglobinuriaChest, 1992
- Sickle Cell Heart DiseaseArchives of internal medicine (1960), 1988
- Pulmonary hypertension and cor pulmonale in the sickle hemoglobinopathiesThe American Journal of Medicine, 1982